Deutsche Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$417M Sell
6,653,275
-94,905
-1% -$7.59M 0.14% 154
2025
Q4
$643M Sell
6,748,180
-1,190,027
-15% -$117M 0.21% 102
2025
Q3
$775M Buy
7,938,207
+389,409
+5% +$40.3M 0.26% 71
2025
Q2
$811M Buy
7,548,798
+2,083,231
+38% +$211M 0.3% 62
2025
Q1
$551M Buy
5,465,567
+26,724
+0.5% +$2.69M 0.22% 97
2024
Q4
$486M Buy
5,438,843
+162,575
+3% +$14.3M 0.19% 106
2024
Q3
$442M Buy
5,276,268
+357,689
+7% +$28.2M 0.18% 112
2024
Q2
$379M Buy
4,918,579
+560,178
+13% +$41M 0.17% 123
2024
Q1
$299M Buy
4,358,401
+302,198
+7% +$19.4M 0.14% 149
2023
Q4
$234M Buy
4,056,203
+688,378
+20% +$36.7M 0.12% 166
2023
Q3
$178M Sell
3,367,825
-78,459
-2% -$4.11M 0.11% 175
2023
Q2
$186M Buy
3,446,284
+423,311
+14% +$22.1M 0.1% 195
2023
Q1
$151M Sell
3,022,973
-228,176
-7% -$10.8M 0.08% 237
2022
Q4
$150M Buy
3,251,149
+607,933
+23% +$26.3M 0.09% 231
2022
Q3
$102M Sell
2,643,216
-126,957
-5% -$5.09M 0.06% 291
2022
Q2
$103M Sell
2,770,173
-345,723
-11% -$14.1M 0.06% 299
2022
Q1
$138M Sell
3,115,896
-139,196
-4% -$6.03M 0.06% 278
2021
Q4
$138M Sell
3,255,092
-2,396,476
-42% -$101M 0.06% 299
2021
Q3
$245M Buy
5,651,568
+2,616,068
+86% +$116M 0.12% 176
2021
Q2
$130M Buy
3,035,500
+293,801
+11% +$12.4M 0.06% 308
2021
Q1
$106M Sell
2,741,699
-398,486
-13% -$15.1M 0.06% 334
2020
Q4
$113M Buy
3,140,185
+922,896
+42% +$33.3M 0.07% 286
2020
Q3
$84.7M Buy
2,217,289
+30,838
+1% +$1.19M 0.06% 302
2020
Q2
$76.8M Buy
2,186,451
+70,508
+3% +$2.54M 0.06% 314
2020
Q1
$69M Sell
2,115,943
-664,925
-24% -$26M 0.06% 300
2019
Q4
$126M Sell
2,780,868
-391,185
-12% -$16.4M 0.08% 255
2019
Q3
$129M Sell
3,172,053
-1,503,187
-32% -$63.7M 0.09% 238
2019
Q2
$201M Sell
4,675,240
-1,764,457
-27% -$67.9M 0.12% 179
2019
Q1
$247M Buy
6,439,697
+3,015,719
+88% +$115M 0.15% 143
2018
Q4
$121M Sell
3,423,978
-3,159,907
-48% -$115M 0.09% 239
2018
Q3
$253M Sell
6,583,885
-2,392,015
-27% -$83.5M 0.13% 151
2018
Q2
$294M Buy
8,975,900
+3,123,996
+53% +$94.2M 0.15% 139
2018
Q1
$160M Buy
5,851,904
+1,487,312
+34% +$40.4M 0.08% 257
2017
Q4
$108M Buy
4,364,592
+1,735,039
+66% +$47.9M 0.07% 295
2017
Q3
$76.7M Sell
2,629,553
-1,520,223
-37% -$42M 0.05% 397
2017
Q2
$115M Buy
4,149,776
+201,435
+5% +$5.35M 0.08% 278
2017
Q1
$98.2M Buy
3,948,341
+1,494,191
+61% +$36.3M 0.07% 308
2016
Q4
$53.1M Sell
2,454,150
-831,829
-25% -$18.2M 0.04% 470
2016
Q3
$78.2M Sell
3,285,979
-1,165,303
-26% -$27.8M 0.06% 369
2016
Q2
$104M Buy
4,451,282
+696,778
+19% +$15.1M 0.07% 306
2016
Q1
$70.6M Sell
3,754,504
-605,723
-14% -$10.6M 0.05% 386
2015
Q4
$80.4M Buy
4,360,227
+1,116,027
+34% +$20M 0.06% 375
2015
Q3
$53.2M Sell
3,244,200
-376,569
-10% -$6.44M 0.04% 475
2015
Q2
$64.1M Buy
3,620,769
+692,783
+24% +$12.4M 0.04% 471
2015
Q1
$52M Sell
2,927,986
-781,126
-21% -$12.3M 0.03% 527
2014
Q4
$49.1M Buy
3,709,112
+704,062
+23% +$9M 0.03% 585
2014
Q3
$35.5M Buy
3,005,050
+985,438
+49% +$12.4M 0.02% 684
2014
Q2
$25.8M Buy
2,019,612
+203,482
+11% +$2.65M 0.02% 799
2014
Q1
$24.6M Sell
1,816,130
-1,281,587
-41% -$16.8M 0.02% 819
2013
Q4
$37.2M Buy
3,097,717
+876,066
+39% +$10.4M 0.03% 612
2013
Q3
$26.1M Sell
2,221,651
-1,472,977
-40% -$15.9M 0.02% 761
2013
Q2
$34.2M Buy
+3,694,628
New +$31.3M 0.03% 611

Other funds holding BSX

Deutsche Bank's BSX Position: Q1 2026 in Review

Deutsche Bank reduced its Boston Scientific (BSX) stake by 1.4% in Q1 2026, selling an estimated $7.59M and leaving 6,653,275 shares worth $417M. The position accounts for 0.14% of the portfolio, ranked #154.

Deutsche Bank first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $811M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Deutsche Bank held 6,653,275 shares of Boston Scientific worth $417M as of Q1 2026.
  • Deutsche Bank sold 94,905 Boston Scientific shares in Q1 2026, an estimated $7.59M.
  • Boston Scientific made up 0.14% of Deutsche Bank's portfolio in Q1 2026, its #154 holding.
  • Deutsche Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Boston Scientific position peaked at $811M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.